MSG
NNVC icon

Main Street Group’s NanoViricides NNVC Stock Holding History

Main Street Group’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-200
Closed -$370 – 835
2024
Q2 		$370 Hold
200
– – ﹤0.01% 809
2024
Q1 		$260 Hold
200
– – ﹤0.01% 864
2023
Q4 		$204 Buy
+200
New +$231 ﹤0.01% 1241

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Compagnie Lombard Odier SCmA
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Integrated Wealth Concepts
Integrated Wealth Concepts Waltham, Massachusetts $15.3B AUM 25.33% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Main Street Group's NNVC Position: Q3 2024 in Review

Main Street Group sold out of NanoViricides (NNVC) in Q3 2024, closing a stake of 200 shares — an estimated $370 sold.

Main Street Group first reported a position in NNVC in Q4 2023 and held it in 3 quarters. The position peaked at $370 in Q2 2024. 32 funds tracked by Wall St. Rank hold NNVC as of Q3 2024.

  • Main Street Group reported no remaining NanoViricides position as of Q3 2024 after selling out during the quarter.
  • Main Street Group sold 200 NanoViricides shares in Q3 2024, an estimated $370.
  • Main Street Group first reported a position in NanoViricides in Q4 2023 and held it in 3 quarters.
  • Main Street Group's NanoViricides position peaked at $370 in Q2 2024.
  • 32 funds tracked by Wall St. Rank held NanoViricides as of Q3 2024.

Based on Main Street Group's 13F filing for Q3 2024, filed 13 Nov 2024.